KAUSHAR DESAI: Open Payments
NPI 1497353999 · GLASTONBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,741 in 145 payments from 12 companies in 2025. Trend: 2023 $931 · 2024 $1,549 · 2025 $1,741
Food & beverage: $1,572Education: $169
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 83 | $719 |
| ABBVIE INC. | 22 | $342 |
| Novartis Pharmaceuticals Corporation | 19 | $220 |
| Amgen Inc. | 7 | $172 |
| UCB, Inc. | 4 | $85 |
| Lilly USA, LLC | 2 | $53 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Alexion Pharmaceuticals, Inc. | 1 | $31 |
| Actelion Pharmaceuticals US, Inc. | 2 | $30 |
| PFIZER INC. | 1 | $19 |
Products named: TREMFYA, COSENTYX, RINVOQ, SKYRIZI, Bimzelx, ENBREL, TALTZ, BENLYSTA.
Industry payments across CT — which companies pay providers there.
